Tag: whole exome sequencing market opportunities

  • 2024 Whole Exome Sequencing Market Overview: Key Insights on Size, Share, and Trends

    2024 Whole Exome Sequencing Market Overview: Key Insights on Size, Share, and Trends

    Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!

    What is the Anticipated Growth Speed of the Whole Exome Sequencing Market Between 2024 and 2033?

    In recent years, the entire exome sequencing market has experienced rapid growth. The market is expected to rise from a valuation of $2.34 billion in 2023 to $2.8 billion in 2024, showing a compound annual growth rate (CAGR) of 19.9%. The remarkable expansion in the past can be ascribed to advancements in genomic research, the emergence of precision medicine, diagnosis of rare diseases, applications in the pharmaceutical and biotech sector, and lower sequencing costs.

    Over the coming years, there is anticipated substantial expansion in the market size of whole exome sequencing. By 2028, it’s predicted to reach $5.89 billion, demonstrating a Compound Annual Growth Rate (CAGR) at 20.4%. The escalating applications in oncology, incorporation in clinical diagnostics, surge in fervor for genetic testing, genomics initiatives at the population level, and the advent of gene therapies, all contribute to the growth in the forecasted period. Other major trends promoting this growth during the projection period are the increased clinical utility and adoption, the diminishing costs associated with sequencing, emphasis on ensuring data security and privacy, integration with electronic health records, and progress in single-cell sequencing.

    Claim Your Free Sample of the Global Whole Exome Sequencing Market Report Today!

    https://www.thebusinessresearchcompany.com/sample.aspx?id=10669&type=smp

    Which Factors Are Enhancing the Growth of the whole exome sequencing Market?

    The rise in HIV (human immunodeficiency virus) cases is likely to foster the development of the whole exome sequencing market. HIV is a virus that impacts the body’s immune system. Whole exome sequencing offers genomic structures of viruses beneficial for creating tailored treatments and vaccine formulations for HIV. For instance, the World Health Organization, a United Nations agency based in Switzerland, reported in April 2023 that HIV continues to be a significant global health issue, with 38.4 million people affected in 2021 and 650,000 fatalities caused by HIV-related complications. Hence, the escalating HIV prevalence is contributing to the expansion of the whole exome sequencing market.

    Which Segments Are Crucial in the Whole Exome Sequencing Market?

    1) By Product: Systems, Kits, Services

    2) By Technology: Sequencing By Synthesis, Ion Semiconductor Sequencing, Other Technologies

    3) By Application: Diagnostics, Drug Discovery And Development, Personalized Medicine, Agriculture And Animal Research

    4) By End-User: Hospitals And Clinics, Pharmaceutical And Biotechnology Companies, Academic and Research Institutes, Clinical Laboratories, Other End-Users

    What Emerging Trends Are Shaping the Future of the Whole Exome Sequencing Market?

    One significant trend emerging in the entire exome sequencing market is the development of novel diagnostic techniques. In order to maintain their market position, companies involved in the whole exome sequencing market are focused on creating innovative products. For example, US biotech firm Illumina Inc., rolled out the most potent sequencing technology, the NovaSeqX Plus, in February 2023. This product offers an unmatched blend of high throughput, accuracy, simplified informatics, sustainability improvements, and cost-effective sequencing. With its innovations built in, the NovaSeq X Plus technology has the capacity to generate tens of thousands of complete genomes annually, optimizing productivity and reducing turnaround time.

    Order Now for Fast Delivery of Your Whole Exome Sequencing Market Report!

    https://www.thebusinessresearchcompany.com/report/whole-exome-sequencing-global-market-report

    What Regions Are At the Forefront of Whole Exome Sequencing Market Expansion?

    North America was the largest region in the whole exome sequencing market in 2023. Asia-Pacific is expected to be the fastest-growing region in the global whole exome sequencing market report during the forecast period. The regions covered in the whole exome sequencing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

    The Whole Exome Sequencing Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the whole exome sequencing market, its market share, and analyzes key competitors along with their market positions.

    The Table Of Content For The Whole Exome Sequencing Market Include

    1. Whole Exome Sequencing Market Executive Summary

    2. Whole Exome Sequencing Market Segments

    3. Whole Exome Sequencing Market Size And Template Market Growth Rate

    4. Key Whole Exome Sequencing Market Trends

    5. Major Whole Exome Sequencing Market Drivers

    ……

    25. Key Mergers And Acquisitions In The Whole Exome Sequencing Market

    26. Top Whole Exome Sequencing Companies

    27. Whole Exome Sequencing Market Opportunities And Strategies

    28. Whole Exome Sequencing Market, Conclusions And Recommendations

    29. Appendix

    Discover Related Reports by The Business Research Company:

    Medical And Diagnostic Laboratory Services Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/medical-and-diagnostic-laboratory-services-global-market-report

    Dental Diagnostic Imaging Devices And Equipment Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/dental-diagnostic-imaging-devices-and-equipment-global-market-report

    Water And Sewage Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/water-and-sewage-global-market-report

    Learn More About The Business Research Company

    The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

    Contact us at:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on:

  • Future Growth Forecast For The Whole Exome Sequencing Global Market 2024-2033

    Future Growth Forecast For The Whole Exome Sequencing Global Market 2024-2033

    The Business Research Company’s global market reports provide comprehensive analysis on the various markets in 27 industries across 60 geographies.

    The whole exome sequencing market has experienced a remarkable surge in recent years, propelled by various factors including genomic research advancements, precision medicine trends, and declining sequencing costs. The market is set to witness exponential growth, expanding from $2.34 billion in 2023 to $2.8 billion in 2024, with a compound annual growth rate (CAGR) of 19.9%.

    The Next Frontier: Projected Growth and Influential Factors

    • Rapid growth anticipated from $2.8 billion in 2024 to $5.89 billion in 2028, at a CAGR of 20.4%.
    • Expansion driven by increasing applications in oncology, clinical diagnostics integration, rising demand for genetic testing, and population genomics initiatives.

    HIV Prevalence Drives Market Expansion

    Rising HIV prevalence globally serves as a significant driver for the whole exome sequencing market. With HIV remaining a major public health concern, whole exome sequencing offers insights into the genomic structures of viruses, facilitating personalized treatment and vaccine designs.

    View More On The Whole Exome Sequencing Market Report 2024 – https://www.thebusinessresearchcompany.com/report/whole-exome-sequencing-global-market-report

    Major Players Shaping the Landscape

    • Thermo Fisher Scientific Inc.
    • Illumina Inc.
    • Eurofins Genomics
    • Azenta US Inc.
    • CD Genomics
    • Hoffmann-La Roche Ltd.
    • QIAGEN Inc.
    • Macrogen Inc.
    • Ambry Genetics
    • Bio-Rad Laboratories Inc.
    • Bioneer Corporation
    • Foundation Medicine Inc.
    • KONICA MINOLTA INC.
    • Otogenetics Corporation
    • Geneyx Genomex Ltd.
    • ArcherDX Inc.
    • Blueprint Genetics Oy
    • Bionano Genomics Inc.
    • Centogene AG

    Innovative Product Offerings Transforming the Market

    • Companies focusing on innovative diagnostic techniques to sustain market position.
    • Illumina Inc. launched NovaSeqX Plus, featuring high throughput, accuracy, and streamlined informatics, revolutionizing sequencing technology.

    Strategic Acquisitions Driving Growth

    • Exact Sciences’ acquisition of Prevention Genetics for $190 million strengthens its cancer testing portfolio, showcasing strategic market consolidation.

    Segmentation of the Whole Exome Sequencing Market

    1. By Product:
      • Systems
      • Kits
      • Services
    2. By Technology:
      • Sequencing By Synthesis
      • Ion Semiconductor Sequencing
      • Other Technologies
    3. By Application:
      • Diagnostics
      • Drug Discovery and Development
      • Personalized Medicine
      • Agriculture and Animal Research
    4. By End-User:
      • Hospitals and Clinics
      • Pharmaceutical and Biotechnology Companies
      • Academic and Research Institutes
      • Clinical Laboratories
      • Other End-Users

    Regional Insights: North America and Asia-Pacific

    • North America dominated the whole exome sequencing market in 2023.
    • Asia-Pacific poised to witness the fastest growth during the forecast period, underscoring its burgeoning demand and adoption of whole exome sequencing technologies.

    Conclusion: Navigating the Future of Whole Exome Sequencing

    In conclusion, the whole exome sequencing market presents lucrative opportunities amidst the backdrop of advancing healthcare technologies and increasing disease prevalence. As companies innovate and expand their offerings, and as strategic acquisitions reshape the market landscape, stakeholders must remain agile to harness the full potential of this dynamic sector.

    In essence, the whole exome sequencing market’s evolution reflects a paradigm shift in healthcare, with personalized medicine and genomic insights playing pivotal roles in diagnosis, treatment, and disease prevention. As the market continues to thrive, it promises to revolutionize healthcare delivery and empower clinicians and researchers with unparalleled precision and efficacy.

    Request A Sample Of The Global Whole Exome Sequencing Market Report 2024:
    https://www.thebusinessresearchcompany.com/sample_request?id=10669&type=smp